These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 11256365)

  • 1. Screening for genetic haemochromatosis in blood samples with raised alanine aminotransferase.
    Paterson J; Toolis F
    Gut; 2001 Mar; 48(3):441-2. PubMed ID: 11256365
    [No Abstract]   [Full Text] [Related]  

  • 2. Screening for genetic haemochromatosis in blood samples with raised alanine aminotransferase.
    Bhavnani M; Lloyd D; Bhattacharyya A; Marples J; Elton P; Worwood M
    Gut; 2000 May; 46(5):707-10. PubMed ID: 10764716
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genotype-based screening for hereditary haemochromatosis. I: Technical performance, costs and clinical relevance of a German pilot study.
    Stuhrmann M; Strassburg C; Schmidtke J
    Eur J Hum Genet; 2005 Jan; 13(1):69-78. PubMed ID: 15483651
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Insurance agreement to facilitate genetic testing.
    Delatycki M; Allen K; Williamson R
    Lancet; 2002 Apr; 359(9315):1433. PubMed ID: 11978360
    [No Abstract]   [Full Text] [Related]  

  • 5. [Using value of information analysis in decision making about applied research. The case of genetic screening for hemochromatosis in Germany].
    Rogowski WH; Grosse SD; Meyer E; John J; Palmer S
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2012 May; 55(5):700-9. PubMed ID: 22526859
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Health insurance company offers genetic screening to its clients.
    Tuffs A
    BMJ; 2004 Dec; 329(7479):1364. PubMed ID: 15591552
    [No Abstract]   [Full Text] [Related]  

  • 7. Diagnostic strategies using DNA testing for hereditary haemochromatosis in at-risk populations: a systematic review and economic evaluation.
    Bryant J; Cooper K; Picot J; Clegg A; Roderick P; Rosenberg W; Patch C
    Health Technol Assess; 2009 Apr; 13(23):iii, ix-xi, 1-126. PubMed ID: 19406046
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Population screening for hemochromatosis.
    Adams PC
    Hepatology; 1999 Apr; 29(4):1324-7. PubMed ID: 10094982
    [No Abstract]   [Full Text] [Related]  

  • 9. Population screening for haemochromatosis.
    Adams PC
    Gut; 2000 Mar; 46(3):301-3. PubMed ID: 10673284
    [No Abstract]   [Full Text] [Related]  

  • 10. Screening for haemochromatosis--producing or preventing illness?
    Adams PC
    Lancet; 2005 Jul 23-29; 366(9482):269-71. PubMed ID: 16039315
    [No Abstract]   [Full Text] [Related]  

  • 11. Hereditary haemochromatosis: to screen or not to screen?
    Olynyk JK; Trinder D; Milward E
    J Hepatol; 2005 Jul; 43(1):9-10. PubMed ID: 15923055
    [No Abstract]   [Full Text] [Related]  

  • 12. Searching for hereditary hemochromatosis.
    Laudicina RJ
    Clin Lab Sci; 2006; 19(3):174-83. PubMed ID: 16910235
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Should asymptomatic haemochromatosis be treated? Alternative strategies to appropriate diagnosis need testing.
    Emery J; Rose P
    BMJ; 2000 Oct; 321(7266):955-6. PubMed ID: 11030697
    [No Abstract]   [Full Text] [Related]  

  • 14. Is DNA testing for hemochromatosis diagnosis reliable?
    Adams PC
    Expert Rev Mol Diagn; 2017 Mar; 17(3):203-204. PubMed ID: 28092202
    [No Abstract]   [Full Text] [Related]  

  • 15. Screening for hereditary haemochromatosis within families and beyond.
    McCune CA; Ravine D; Worwood M; Jackson HA; Evans HM; Hutton D
    Lancet; 2003 Dec; 362(9399):1897-8. PubMed ID: 14667749
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Haemochromatosis and family testing. What should a GP do?
    Newstead J; Delatycki M; Aitken MA
    Aust Fam Physician; 2002 Jun; 31(6):533-7. PubMed ID: 12154600
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Screening blood donors for hereditary hemochromatosis: decision analysis model comparing genotyping to phenotyping.
    Adams PC; Valberg LS
    Am J Gastroenterol; 1999 Jun; 94(6):1593-600. PubMed ID: 10364030
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Summaries for patients. Screening for hemochromatosis: recommendations from the U.S. Preventive Services Task Force.
    Ann Intern Med; 2006 Aug; 145(3):I18. PubMed ID: 16880456
    [No Abstract]   [Full Text] [Related]  

  • 19. Automated measurement of unsaturated iron binding capacity is an effective screening strategy for C282Y homozygous haemochromatosis.
    Hickman PE; Hourigan LF; Powell LW; Cordingley F; Dimeski G; Ormiston B; Shaw J; Ferguson W; Johnson M; Ascough J; McDonell K; Pink A; Crawford DH
    Gut; 2000 Mar; 46(3):405-9. PubMed ID: 10673305
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The cost-effectiveness of screening for hereditary hemochromatosis in Germany: a remodeling study.
    Rogowski WH
    Med Decis Making; 2009; 29(2):224-38. PubMed ID: 19182214
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.